Waters Corporation (WAT) Stock Looks Poised for New Highs

Page 1 of 2

Waters Corporation (NYSE:WAT) is far from a household name among most investors. But millions of investors who use S&P 500 index funds as part of their investing strategy indirectly own shares of the medical-technology company, and those who’ve bought shares directly have to be pleased with the performance that Waters stock has given them recently.

But given the nice returns that the company has provided, investors should ask whether Waters Corporation (NYSE:WAT) has the potential to keep growing. Let’s take a look at this little-known company to find out where its best prospects lie and how Waters is moving forward to try to capitalize on them.

What Waters does
Waters Corporation (NYSE:WAT) works to help scientists in numerous fields perform scientific analysis, with instruments that assist in the fields of liquid chromatography, mass spectrometry, and thermal analysis. Its products have application throughout the scientific professions, with companies in the pharmaceutical, life sciences, biochemical, and industrial sectors all having occasion to work with Waters to help them with develop and analyze their efforts in coming up with their own scientific innovations. With a history of that goes back 50 years, Waters’ first major client was The Dow Chemical Company (NYSE:DOW), which invested $400,000 in the young company and eventually took a substantial stake in Waters before it merged with biosciences company Millipore in 1980.

Waters Corporation (NYSE:WAT) now has operations that span the globe, getting roughly 30% of its revenue from the U.S., a similar amount from Europe, and the remainder mostly from Japan, China, and other Asian countries. Given the substantial increase in scientific and industrial activity in Asia in recent decades, the region remains an important driver of growth for Waters.

How Waters stands up to the competition
Since coming public in 1995, the stock has performed extremely well, rising at an average annual clip of more than 17%.

WAT Total Return Price Chart

Waters Total Return Price data by YCharts.

But Waters Corporation (NYSE:WAT) is far from the only company serving the scientific community. Thermo Fisher Scientific Inc. (NYSE:TMO) is the giant in the industry, with more than six times as many employees as Waters and seven times the revenue that Waters generates. Moreover, Thermo Fisher is only poised to get larger in the near future, as the company announced in April that it would acquire Life Technologies Corp. (NASDAQ:LIFE) for $13.6 billion. The deal will give Thermo Fisher exposure to the promising genomic testing industry — an area that has seen increasing growth as the costs of genetic analysis have come down and therefore begun to inspire more commercial viable applications — and shows the rewards available to investors in companies like Life Technologies given the trend toward consolidation in the industry. Agilent Technologies Inc. (NYSE:A) is another major player in medical- and chemical-lab equipment, with its own liquid chromatography, mass spectrometry, and genomics capability. Despite recent challenges, Agilent still represents a threat to Waters’ growth.

Why Waters has potential
In its most recent quarterly conference call, Waters Corporation (NYSE:WAT) executives indicated that they seemed content with the company’s overall strategy going forward, with continued solid growth and conservative capital allocation. With its Alliance system providing quality control for makers of generic drugs, demand for generic versions of an increasing number of off-patent drugs should help Waters keep growing in the pharmaceutical segment. Meanwhile, Waters has seen a ramp-up in sales for mass spectrometry systems, encouraging the company as it rolls out advanced systems to maintain its leadership role in the industry. In China, Waters noted demand not only for traditional life-science and industrial instruments but also for equipment to analyze food quality and safety.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!